Related scientific articles (all)

Initiation of a new anti-cancer medical treatment in ICU: a retrospective study.

Authors : Chicoisneau M, Paesmans M, Ameye L, Sculier JP, Meert AP
Year : 2022
Journal : Acta Clin Belg
Volume : 77
Pages : 337-345

Editorial: Psychological interventions in oncology: advances and challenges.

Authors : Libert Y, Merckaert I, Klastersky JA
Year : 2022
Journal : Curr Opin Oncol
Volume : 34
Pages : 253-255

Suspicious cold thyroid nodule with intense focal 68Ga-DOTATATE uptake: a case report.

Authors : Manta R, Delbart W, Duran Derijckere I, Quiriny M, Demetter P, Flamen P, Karfis I
Year : 2022
Journal : Eur J Hybrid Imaging
Volume : 6
Pages : 8

Efficacy and Safety of Tranexamic Acid in Cancer Surgery. An Update of Clinical Findings and Ongoing Research.

Authors : Zec T, Di Napoli R, Fievez L, Ben Aziz M, Ottaiano A, Vittori A, Perri F, Cascella M
Year : 2022
Journal : J Multidiscip Healthc
Volume : 15
Pages : 1427-1444

Knowledge, Practice, and Attitudes of Physicians in Low- and Middle-Income Countries on Fertility and Pregnancy-Related Issues in Young Women With Breast Cancer.

Authors : Khan SZ, Arecco L, Villarreal-Garza C, Sirohi B, Ponde NF, Habeeb B, Brandão M, Azim HA Jr, Chowdhury AR, Bozovic-Spasojevic I, Kovalenko I, Odhiambo A, Seid FU, Mutombo AB, Petracci F, Vidra R, Altuna SC, Petrova M, Kourie HR, Ozturk MA, Razeti MG, Lengyel CG, Talibova N, Mariamidze E, Sacardo KP, Duma N, Gyawali B, Trapani D, Tagliamento M, Lambertini M
Year : 2022
Journal : JCO Glob Oncol
Volume : 8
Pages : e2100153

Recommendations on the management of multiple myeloma in 2020.

Authors : Vekemans MC, Doyen C, Caers J, Wu K, Kentos A, Mineur P, Michaux L, Delforge M, Meuleman N
Year : 2022
Journal : Acta Clin Belg
Volume : 77
Pages : 445-461

Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial.

Authors : Felip E, Smit EF, Molina-Vila MA, Dafni U, Massuti B, Berghmans T, de Marinis F, Passiglia F, Dingemans AC, Cobo M, Viteri S, Britschgi C, Cuffe S, Provencio M, Merkelbach-Bruse S, Andriakopoulou C, Kammler R, Ruepp B, Roschitzki-Voser H, Peters S, Wolf J, Stahel R
Year : 2022
Journal : Lung Cancer
Volume : 172
Pages : 94-99

Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2.

Authors : Goel S, Tan AR, Rugo HS, Aftimos P, Beelen A, Zhang J, Yi JS, Malik R, OShaughnessy J
Year : 2022
Journal : Future Oncol
Volume : 18
Pages : 3701-3711

Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma.

Authors : Leupin N, Zinzani PL, Morschhauser F, Dalle S, Maerevoet M, Michot JM, Ribrag V, Offner F, Beylot-Barry M, Moins-Teisserenc H, Zwaenepoel K, de Winne K, Battistella M, Hultberg A, Gandini D, Moshir M, Jacobs J, Delahaye T, Khan A, Zabrocki P, Silence K, Van Rompaey L, Borg C, Motta G, Melle F, Calleri A, Pauwels P, de Haard H, Pileri S, Bagot M
Year : 2022
Journal : Cancer
Volume : 128
Pages : 1004-1014

Antimicrobial susceptibility testing determined by Alfred 60/AST (Alifax®) in a multi-sites lab: performance's evaluation and optimization of workflow.

Authors : Cupaiolo R, Cherkaoui S, Serrano G, Dauby N, Georgala A, Blumental S, Maillart E, Hites M, Hallin M, Martiny D
Year : 2022
Journal : J Microbiol Methods
Volume : 194
Pages : 106433

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).

Authors : Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH
Year : 2022
Journal : Eur Heart J
Volume : 43
Pages : 4229-4361

Biomarkers and immunotherapy: where are we?

Authors : Langouo Fontsa M, Padonou F, Willard-Gallo K
Year : 2022
Journal : Curr Opin Oncol
Volume : 34
Pages : 579-586

Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice.

Authors : Delforge M, Vekemans MC, Depaus J, Meuleman N, Van de Velde A, Vande Broek I, Vandervennet S, Van Hoorenbeeck S, Moorkens E, Strens D, Diels J, Ghilotti F, Haefliger B, Dalhuisen S, Deraedt W, Anguille S
Year : 2022
Journal : Hemasphere
Volume : 6
Pages : e813

Molecular oncology: what is needed to speed access to innovative therapies in clinical research?

Authors : Gourari K, Awada A, Kotecki N
Year : 2022
Journal : Curr Opin Oncol
Volume : 34
Pages : 575-578

Qualitative evaluation of the role of RTTs IGRT specialists and their influence on treatment delivery.

Authors : Sousa F, Somoano M, Jourani Y, Van Gestel D
Year : 2022
Journal : Tech Innov Patient Support Radiat Oncol
Volume : 22
Pages : 9-15

Extracellular vesicle secretion by leukemia cells in vivo promotes CLL progression by hampering antitumor T-cell responses.

Authors : Gargiulo E, Viry E, Morande PE, Largeot A, Gonder S, Xian F, Ioannou N, Benzarti M, Kleine Borgmann FB, Mittelbronn M, Dittmar G, Nazarov PV, Meiser J, Stamatopoulos B, Ramsay AG, Moussay E, Paggetti J
Year : 2022
Journal : Blood Cancer Discov

Line-field confocal optical coherence tomography as a tool for three-dimensional in vivo quantification of healthy epidermis: A pilot study.

Authors : Chauvel-Picard J, Bérot V, Tognetti L, Orte Cano C, Fontaine M, Lenoir C, Pérez-Anker J, Puig S, Dubois A, Forestier S, Monnier J, Jdid R, Cazorla G, Pedrazzani M, Sanchez A, Fischman S, Rubegni P, Del Marmol V, Malvehy J, Cinotti E, Perrot JL, Suppa M
Year : 2022
Journal : J Biophotonics
Volume : 15
Pages : e202100236

Breast Reconstruction Perforator Flaps

Authors : Ben Aziz M, Rose J
Year : 2022
Journal : StatPearls

First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers.

Authors : Harding JJ, Awada A, Roth G, Decaens T, Merle P, Kotecki N, Dreyer C, Ansaldi C, Rachid M, Mezouar S, Menut A, Bestion EN, Paradis V, Halfon P, Abou-Alfa GK, Raymond E
Year : 2022
Journal : Liver Cancer
Volume : 11
Pages : 268-277

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).

Authors : Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH
Year : 2022
Journal : Eur Heart J Cardiovasc Imaging
Volume : 23
Pages : e333-e465